Abvc Biopharma (ABVC) Long-Term Debt Repayments (2019 - 2024)

Abvc Biopharma (ABVC) has reported Long-Term Debt Repayments for 5 consecutive years, with $147892.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Long-Term Debt Repayments changed N/A year-over-year to $147892.0; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (changed 0.0% YoY), and the FY2025 full-year result was $277284.0, down 15.21% from the prior year.
• Long-Term Debt Repayments eased to $147892.0 in Q4 2024 per ABVC's latest filing, from $1.0 million in the prior quarter.
• Across five years, Long-Term Debt Repayments topped out at $1.0 million in Q1 2023 and bottomed at $121.0 in Q3 2020.
• Historically, Long-Term Debt Repayments has averaged $245458.7 across 4 years, with a median of $147892.0 in 2024.
• The widest YoY moves for Long-Term Debt Repayments: up 2716.28% in 2020, down 99.05% in 2020.
• Over 4 years, Long-Term Debt Repayments stood at $121.0 in 2020, then surged by 46871.9% to $56836.0 in 2021, then jumped by 1659.45% to $1.0 million in 2023, then sank by 85.21% to $147892.0 in 2024.
• According to Business Quant data, Long-Term Debt Repayments over the past three periods registered $147892.0, $1.0 million, and $56836.0 for Q4 2024, Q1 2023, and Q2 2021 respectively.